As PCNA is a new and unexplored target for cancer treatment, we have here investigated the regulatory role of PCNA in 10 multiple myeloma (MM) cell lines using a multi-omics approach and a PCNA-targeting peptide, ATX-101, currently in clinical development. Here, PCNA is linked to Miyoshi myopathy.